Rapid and Highly Efficient CRISPR-Cas9 RNP Genome Editing in Primary ILC2s.

Authors

Arianna Maria Candelotti, Giordana Garzillo, Sara Bartolini, Chiara Di Censo, Giovanna Peruzzi, Helena Stabile, Cinzia Fionda, Giuseppe Sciumè, Giuseppe Pietropaolo

Published in

European journal of immunology. Volume 56. Issue 8. Pages e70254.

Abstract

CRISPR-mediated gene editing enables efficient genetic manipulation of ILC2s through ex vivo or in vivo activation and Cas9 RNP delivery. This platform provides a robust approach to dissect gene function in ILC2s, with minimal manipulation.

PMID:
42609038
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.